Cited by 2,763Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 404 of the 409 references it cites were found in a registry or an index.

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Beaulieu, Jean-Martin, Gainetdinov, Raul R.·2011·Pharmacological Reviews

DOI 10.1124/pr.110.002642

Open this paper in CoChat — free account

Abstract

G protein-coupled dopamine receptors (D1, D2, D3, D4, and D5) mediate all of the physiological functions of the catecholaminergic neurotransmitter dopamine, ranging from voluntary movement and reward to hormonal regulation and hypertension. Pharmacological agents targeting dopaminergic neurotransmission have been clinically used in the management of several neurological and psychiatric disorders, including Parkinson's disease, schizophrenia, bipolar disorder, Huntington's disease, attention deficit hyperactivity disorder (ADHD(1)), and Tourette's syndrome. Numerous advances have occurred in understanding the general structural, biochemical, and functional properties of dopamine receptors that have led to the development of multiple pharmacologically active compounds that directly target dopamine receptors, such as antiparkinson drugs and antipsychotics. Recent progress in understanding the complex biology of dopamine receptor-related signal transduction mechanisms has revealed that, in addition to their primary action on cAMP-mediated signaling, dopamine receptors can act through diverse signaling mechanisms that involve alternative G protein coupling or through G protein-independent mechanisms via interactions with ion channels or proteins that are characteristically implicated in receptor desensitization, such as β-arrestins. One of the future directions in managing dopamine-related pathologic conditions may involve a transition from the approaches that directly affect receptor function to a precise targeting of postreceptor intracellular signaling modalities either directly or through ligand-biased signaling pharmacology. In this comprehensive review, we discuss dopamine receptor classification, their basic structural and genetic organization, their distribution and functions in the brain and the periphery, and their regulation and signal transduction mechanisms. In addition, we discuss the abnormalities of dopamine receptor expression, function, and signaling that are documented in human disorders and the current pharmacology and emerging trends in the development of novel therapeutic agents that act at dopamine receptors and/or on related signaling events.

Integrity signals

Registry

Crossref · 10.1124/pr.110.002642

Cites

404 of 404 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,756
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Seven-transmembrane receptors
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220

Show all 409 references

Sorted by citations

Items 101–200 of 1,006

Dopaminergic modulation of striatal networks in health and Parkinson's disease
Surmeier, D. J., Graves, S. M., & Shen, W. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.008 · Cited by 159
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
Zhang, K., Zhu, S., Li, J., Jiang, T., Feng, L., Pei, J., Wang, G., Ouyang, L., & Liu, B. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.016 · Cited by 159
Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation
Luciana, M., Wahlstrom, D., Porter, J. N., & Collins, P. F. (2012) · Developmental Psychology · doi:10.1037/a0027432 · Cited by 156
Potential avenues for exercise to activate episodic memory‐related pathways: a narrative review
Loprinzi, P. D., Edwards, M. K., & Frith, E. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13644 · Cited by 156
Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes
Xiao, P., Yan, W., Gou, L., Zhong, Y.-N., Kong, L., Wu, C., Wen, X., Yuan, Y., Cao, S., Qu, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.028 · Cited by 154
Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
Coppen, E. M., & Roos, R. A. C. (2016) · Drugs · doi:10.1007/s40265-016-0670-4 · Cited by 152
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy
Law, A. J., Wang, Y., Sei, Y., O’Donnell, P., Piantadosi, P., Papaleo, F., Straub, R. E., Huang, W., Thomas, C. J., Vakkalanka, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206118109 · Cited by 147
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
Li, J., Zhu, S., Kozono, D., Ng, K., Futalan, D., Shen, Y. H., Akers, J. C., Steed, T., Kushwaha, D. S., Schlabach, M. R., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1801 · Cited by 147
From Molecules to Management: Mechanisms and Consequences of Locust Phase Polyphenism
Cullen, D. A., Cease, A., Latchininsky, A. V., Ayali, A., Berry, K., Buhl, C., Keyser, R. D., Foquet, B., Hadrich, J. C., Matheson, T., et al. (2017) · Advances in insect physiology · doi:10.1016/bs.aiip.2017.06.002 · Cited by 147
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
Leo, D., Mus, L., Espinoza, S., Hoener, M. C., Sotnikova, T. D., & Gainetdinov, R. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.007 · Cited by 146
Self-citation
Implication of coumarins towards central nervous system disorders
Skalicka‐Woźniak, K., Orhan, İ. E., Cordell, G. A., Nabavi, S. M., & Budzyńska, B. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.023 · Cited by 146
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
Tan, L., Yan, W., McCorvy, J. D., & Cheng, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00435 · Cited by 145
Dopamine D 1 or D 2 receptor‐expressing neurons in the central nervous system
Wei, X., Ma, T., Cheng, Y., Huang, C. C., Wang, X., Lu, J., & Wang, J. (2017) · Addiction Biology · doi:10.1111/adb.12512 · Cited by 146
Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine
Capellino, S., Claus, M., & Watzl, C. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0477-9 · Cited by 144
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
da Silva, B. S., Grevet, E. H., Silva, L. C. F., Ramos, J. K. N., Rovaris, D. L., & Bau, C. H. D. (2023) · Discover Mental Health · doi:10.1007/s44192-022-00030-1 · Cited by 146
Brain Human Monoclonal Autoantibody from Sydenham Chorea Targets Dopaminergic Neurons in Transgenic Mice and Signals Dopamine D2 Receptor: Implications in Human Disease
Cox, C. J., Sharma, M., Leckman, J. F., Zuccolo, J., Zuccolo, A., Kovoor, A., Swedo, S. E., & Cunningham, M. W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1102592 · Cited by 143
Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
Bartzokis, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.015 · Cited by 142
Randomized controlled trial evaluating the temporal effects of high‐intensity exercise on learning, short‐term and long‐term memory, and prospective memory
Frith, E., Sng, E., & Loprinzi, P. D. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13719 · Cited by 142
Dopamine’s Effects on Corticostriatal Synapses during Reward-Based Behaviors
Bamford, N. S., Wightman, R. M., & Sulzer, D. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.006 · Cited by 142
Dopamine midbrain neurons in health and Parkinson’s disease: Emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels
Dragicevic, E., Schiemann, J. M., & Liss, B. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.037 · Cited by 141
Immunomodulatory Effects Mediated by Dopamine
Arreola, R., Álvarez-Herrera, S., Pérez‐Sánchez, G., Becerril‐Villanueva, E., Cruz-Fuentes, C. S., Flores-Gutiérrez, E. O., Garcés-Alvarez, M. E., de la Cruz-Aguilera, D. L., Medina‐Rivero, E., Hurtado‐Alvarado, G., et al. (2016) · Journal of Immunology Research · doi:10.1155/2016/3160486 · Cited by 141
A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons
Farrell, M. S., Pei, Y., Wan, Y., Yadav, P. N., Daigle, T. L., Urban, D. J., Lee, H.-M., Sciaky, N., Simmons, A., Nonneman, R. J., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.251 · Cited by 140
Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action
Ostadkarampour, M., & Putnins, E. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.676239 · Cited by 138
The role of dopamine receptors in the neurotoxicity of methamphetamine
Ares‐Santos, S., Granado, N., & Moratalla, R. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12049 · Cited by 138
Dopamine
Costa, K. M., & Schoenbaum, G. M. (2022) · Current Biology · doi:10.1016/j.cub.2022.06.060 · Cited by 136
Distinct Synaptic Strengthening of the Striatal Direct and Indirect Pathways Drives Alcohol Consumption
Cheng, Y., Huang, C. C., Ma, T., Wei, X., Wang, X., Lu, J., & Wang, J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.016 · Cited by 135
Mechanisms of neuromodulatory volume transmission
Özçete, Ö. D., Banerjee, A., & Kaeser, P. S. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02608-3 · Cited by 144
Dopaminergic transmission rapidly and persistently enhances excitability of D1 receptor-expressing striatal projection neurons
Lahiri, A. K., & Bevan, M. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.028 · Cited by 133
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
Sánchez‐Blázquez, P., Rodríguez-Muñoz, M., & Garzón, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00169 · Cited by 131
Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity
Tuplin, E. W. N., & Holahan, M. R. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170413115754 · Cited by 131
Dopaminergic Regulation of Innate Immunity: a Review
Pinoli, M., Marino, F., & Cosentino, M. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9749-2 · Cited by 131
Circadian insights into dopamine mechanisms
Mendoza, J., & Challet, É. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.081 · Cited by 130
Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Pignalosa, F. C., Desiderio, A., Mirra, P., Nigro, C., Perruolo, G., Ulianich, L., Formisano, P., Bèguinot, F., Miele, C., Napoli, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212366 · Cited by 130
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
Gardoni, F., & Bellone, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00025 · Cited by 129
PV plasticity sustained through D1/5 dopamine signaling required for long-term memory consolidation
Karunakaran, S., Chowdhury, A., Donato, F., Quairiaux, C., Michel, C. M., & Caroni, P. (2016) · Nature Neuroscience · doi:10.1038/nn.4231 · Cited by 129
Electrochemical Fouling of Dopamine and Recovery of Carbon Electrodes
Peltola, E., Sainio, S., Holt, K. B., Palomäki, T., Koskinen, J., & Laurila, T. T. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04793 · Cited by 129
Pharmacology and perspectives in erectile dysfunction in man
Mitidieri, E., Cirino, G., Bianca, R. D. D. V., & Sorrentino, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107493 · Cited by 130
Olfactory Bulb Short Axon Cell Release of GABA and Dopamine Produces a Temporally Biphasic Inhibition–Excitation Response in External Tufted Cells
Liu, S., Plachez, C., Shao, Z., Puché, A. C., & Shipley, M. T. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3607-12.2013 · Cited by 128
Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons
Dragicevic, E., Pötschke, C., Duda, J., Schlaudraff, F., Lammel, S., Schiemann, J. M., Fauler, M., Hetzel, A., Watanabe, M., Luján, R., et al. (2014) · Brain · doi:10.1093/brain/awu131 · Cited by 128
Hypothalamic dopamine neurons motivate mating through persistent cAMP signalling
Zhang, S. X., Lutas, A., Yang, S., Diaz, A., Fluhr, H., Nagel, G., Gao, S., & Andermann, M. L. (2021) · Nature · doi:10.1038/s41586-021-03845-0 · Cited by 128
Ultra-Processed Food, Reward System and Childhood Obesity
Calcaterra, V., Cena, H., Rossi, V., Santero, S., Bianchi, A., & Zuccotti, G. (2023) · Children · doi:10.3390/children10050804 · Cited by 129
Evidence against dopamine D1/D2 receptor heteromers
Frederick, A. L., Yano, H., Trifilieff, P., Vishwasrao, H. D., Biezonski, D. K., Mészáros, J., Urizar, E. T., Sibley, D. R., Kellendonk, C., Sonntag, K., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.166 · Cited by 127
Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
Deurwaerdère, P. D., Giovanni, G. D., & Millan, M. J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.002 · Cited by 127
The social transmission of metacontrol policies: Mechanisms underlying the interpersonal transfer of persistence and flexibility
Hommel, B., & Colzato, L. S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.009 · Cited by 127
Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations
Lee, Y., Basith, S., & Choi, S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01453 · Cited by 126
Calcium signaling in Parkinson’s disease
Calí, T., Ottolini, D., & Brini, M. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1866-0 · Cited by 124
A new mechanism of allostery in a G protein–coupled receptor dimer
Lane, J. R., Donthamsetti, P., Shonberg, J., Draper-Joyce, C. J., Dentry, S., Michino, M., Shi, L., López, L., Scammells, P. J., Capuano, B., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1593 · Cited by 124
The NMDA receptor complex: a multifunctional machine at the glutamatergic synapse
Fan, X., Jin, W. Y., & Wang, Y. T. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00160 · Cited by 124
New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
Urs, N. M., Peterson, S. M., & Caron, M. G. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.011 · Cited by 124
The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models
MacDonald, H. J., Kleppe, R., Szigetvari, P. D., & Haavik, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1492126 · Cited by 124
Infectious agents and Alzheimer's disease
Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102073 · Cited by 123
BRET biosensors to study GPCR biology, pharmacology, and signal transduction
Salahpour, A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00105 · Cited by 123
Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review
Prata, D. P., Costa-Neves, B., Cosme, G., & Vassos, E. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.007 · Cited by 123
The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates
Wang, H., Wang, Z., & Chen, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105542 · Cited by 122
Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: Focus on nicotine effects
Pistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 120
Genetic variation and dopamine D2 receptor availability: a systematic review and meta-analysis of human in vivo molecular imaging studies
Gluskin, B. S., & Mickey, B. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.22 · Cited by 119
The Electroretinogram as a Biomarker of Central Dopamine and Serotonin: Potential Relevance to Psychiatric Disorders
Lavoie, J., Illiano, P., Sotnikova, T. D., Gainetdinov, R. R., Beaulieu, J., & Hébert, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.024 · Cited by 119
Self-citation
What Can Crystal Structures of Aminergic Receptors Tell Us about Designing Subtype-Selective Ligands?
Michino, M., Beuming, T., Donthamsetti, P., Newman, A. H., Javitch, J. A., & Shi, L. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009944 · Cited by 118
GPCR crystal structures: Medicinal chemistry in the pocket
Shonberg, J., Kling, R. C., Gmeiner, P., & Löber, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.034 · Cited by 118
Classics in Chemical Neuroscience: Aripiprazole
Casey, A. B., & Canal, C. E. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00087 · Cited by 118
GRK2-Mediated Inhibition of Adrenergic and Dopaminergic Signaling in Right Ventricular Hypertrophy
Piao, L. H., Fang, Y., Parikh, K. S., Ryan, J. J., D’Souza, K. M., Theccanat, T., Tóth, P. T., Pogoriler, J. E., Paul, J., Blaxall, B. C., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.109868 · Cited by 118
Genetic Overlap Between Schizophrenia and Volumes of Hippocampus, Putamen, and Intracranial Volume Indicates Shared Molecular Genetic Mechanisms
Smeland, O. B., Wang, Y., Frei, O., Li, W., Hibar, D. P., Franke, B., Bettella, F., Witoelar, A., Djurovic, S., Chen, C., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx148 · Cited by 118
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update
Prasad, E. M., & Hung, S. (2021) · Pharmaceuticals · doi:10.3390/ph14080717 · Cited by 118
Regulation of GABAARs by Phosphorylation
Nakamura, Y., Darnieder, L. M., Deeb, T. Z., & Moss, S. J. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.11.008 · Cited by 118
Phosphorylation of Ser1166 on GluN2B by PKA Is Critical to Synaptic NMDA Receptor Function and Ca2+Signaling in Spines
Murphy, J. A., Stein, I. S., Lau, C. G., Peixoto, R. T., Aman, T. K., Kaneko, N., Aromolaran, K. A., Saulnier, J. L., Popescu, G., Sabatini, B. L., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4538-13.2014 · Cited by 118
Dopamine Regulation of Gonadotropin-Releasing Hormone Neuron Excitability in Male and Female Mice
Liu, X., & Herbison, A. E. (2012) · Endocrinology · doi:10.1210/en.2012-1602 · Cited by 118
Passion, grit and mindset in young adults: Exploring the relationship and gender differences
Sigmundsson, H., Haga, M., & Hermundsdottir, F. (2020) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2020.100795 · Cited by 117
The basal ganglia: motor and cognitive relationships in a clinical neurobehavioral context
Leisman, G., & Melillo, R. J. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0067 · Cited by 117
Dopaminergic innervation and modulation of hippocampal networks
Edelmann, E., & Leßmann, V. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2800-7 · Cited by 117
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Feng, Y., & Lü, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663102 · Cited by 113
Presynaptic D2 Dopamine Receptors Control Long-Term Depression Expression and Memory Processes in the Temporal Hippocampus
Rocchetti, J., Isingrini, E., Bo, G. D., Sagheby, S., Menegaux, A., Tronche, F., Lévesque, D., Moquin, L., Gratton, A. P., Wong, T. P., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.03.013 · Cited by 113
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations
Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112
Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation
Ferrazzoli, D., Ortelli, P., Madeo, G., Giladi, N., Petzinger, G. M., & Frazzitta, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.007 · Cited by 112
Toxoplasmosis: A pathway to neuropsychiatric disorders
Tyebji, S., Seizova, S., Hannan, A. J., & Tonkin, C. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.012 · Cited by 112
Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways
Rębas, E., Rzajew, J., Radzik, T., & Żylińska, L. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200106155127 · Cited by 112
Polydopamine films: Electrochemical growth and sensing applications
Szewczyk, J., Aguilar‐Ferrer, D., & Coy, E. L. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111346 · Cited by 112
Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression
Giordano, G., Tait, L. J., Furlong, C. E., Cole, T. B., Kavanagh, T. J., & Costa, L. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.019 · Cited by 112
Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders
Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111
Dopaminergic and cholinergic learning mechanisms in nicotine addiction
Subramaniyan, M., & Dani, J. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12871 · Cited by 110
Does Vitamin C Deficiency Affect Cognitive Development and Function?
Hansen, S. L., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2014) · Nutrients · doi:10.3390/nu6093818 · Cited by 111
Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway
Purves-Tyson, T. D., Owens, S. J., Double, K. L., Desai, R., Handelsman, D. J., & Weickert, C. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091151 · Cited by 109
Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond
Groß, C., Berry‐Kravis, E., & Bassell, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.137 · Cited by 109
Gut microbes participate in food preference alterations during obesity
d’Oplinter, A. D. W., Rastelli, M., Hul, M. V., Delzenne, N. M., Cani, P. D., & Everard, A. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1959242 · Cited by 112
Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs
Boyd, K. N., & Mailman, R. B. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_3 · Cited by 109
The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions
Groß, G., & Drescher, K. U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_7 · Cited by 109
COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review
Schacht, J. P. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.43 · Cited by 108
Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens
Karkhanis, A. N., Rose, J. H., Huggins, K. N., Konstantopoulos, J. K., & Jones, S. R. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.019 · Cited by 108
Electrophysiological properties of NG2 + cells: Matching physiological studies with gene expression profiles
Larson, V. A., Zhang, Y., & Bergles, D. E. (2015) · Brain Research · doi:10.1016/j.brainres.2015.09.010 · Cited by 107
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models
Lyon, L., Saksida, L. M., & Bussey, T. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2536-5 · Cited by 107
Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's Chorea
Ben‐Pazi, H., Stoner, J. A., & Cunningham, M. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073516 · Cited by 107
Peripheral and Central Effects of Circulating Catecholamines
William Tank, A., & Lee Wong, D. (2015) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2015.tb00599.x · Cited by 106
Dopamine Triggers the Maturation of Striatal Spiny Projection Neuron Excitability during a Critical Period
Lieberman, O. J., McGuirt, A. F., Mosharov, E. V., Pigulevskiy, I., Hobson, B. D., Choi, S., Frier, M. D., Santini, E., Borgkvist, A., & Sulzer, D. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.044 · Cited by 106
Sex Differences in Dopamine Receptors and Relevance to Neuropsychiatric Disorders
Williams, O. O. F., Coppolino, M., George, S. R., & Perreault, M. L. (2021) · Brain Sciences · doi:10.3390/brainsci11091199 · Cited by 106
Current drug treatments targeting dopamine D3 receptor
Leggio, G. M., Bucolo, C., Platania, C. B. M., Salomone, S., & Drago, F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.007 · Cited by 105
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
Kuštrimović, N. Z., Rasini, E., Legnaro, M., Bombelli, R., Aleksić, I., Blandini, F., Comi, C., Mauri, M. F., Minafra, B., Riboldazzi, G., et al. (2016) · Scientific Reports · doi:10.1038/srep33738 · Cited by 105
The long-term effects of cocaine use on cognitive functioning: A systematic critical review
Frazer, K. M., Richards, Q., & Keith, D. R. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.04.005 · Cited by 105
Rotigotine is a potent agonist at dopamine D 1 receptors as well as at dopamine D 2 and D 3 receptors
Wood, M. D., Dubois, V., Scheller, D., & Gillard, M. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12988 · Cited by 105
Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling
Solís, Ó., García-Montes, J. R., González-Granillo, A. E., Xu, M., & Moratalla, R. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv231 · Cited by 104
Dopamine D1 receptor subtype mediates acute stress-induced dendritic growth in excitatory neurons of the medial prefrontal cortex and contributes to suppression of stress susceptibility in mice
Shinohara, R., Taniguchi, M., Ehrlich, A. T., Yokogawa, K., Deguchi, Y., Chérasse, Y., Lazarus, M., Urade, Y., Ogawa, A., Kitaoka, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.177 · Cited by 105

Authors: Beaulieu, J.-M., & Gainetdinov, R. R.
Affiliations: Université Laval (CA)
Italian Institute of Technology (IT)
ORCID: Beaulieu, Jean-Martin
Gainetdinov, Raul R.
Venue: Pharmacological Reviews
Publisher: Elsevier BV
Published: 2011-03
Volume: 63
Issue: 1
Pages: 182-217
ISSN: 0031-6997 (ISSN-L)
DOI: 10.1124/pr.110.002642
OpenAlex: W2097744565
Cited by: 2,763
References: 409
Citations by year: 2026: 157 · 2025: 183 · 2024: 172 · 2023: 193 · 2022: 201 · 2021: 197 · 2020: 198 · 2019: 220 · 2018: 200 · 2017: 187 · 2016: 205 · 2015: 175 · 2014: 194 · 2013: 136 · 2012: 101
FWCI: 13.93
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacological Reviews (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Institutes of Health Research (NSA93798)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: dopamine receptors, dopamine D1/D5 receptors, G protein-coupled receptors, signal transduction, cAMP signaling, G protein-independent signaling, beta-arrestin, receptor desensitization, antiparkinsonian drugs, antipsychotic drugs
MeSH terms: Animals, Gene Expression Regulation, Humans, Ligands, Receptors, Dopamine, Signal Transduction, Dopamine Agonists, Dopamine Antagonists, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks